Pharmafile Logo
Pharmafocus logo
Advanced Search

AbbVie UK

Showing 1 posts of 1 posts found.

Migraine annual economic and quality-of-life burden in UK

October 1, 2026
AbbVie UK, Health Innovation Manchester, migraine, quality-of-life burden

Migraine affects an estimated 280,000 people across Greater Manchester and creates an annual economic and quality-of-life burden of around £870m, …

News
The Gateway to Local Adoption Series

Latest content

Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials

November 11, 2026

START and Rome cancer institute partner to expand early-phase trial access in Italy

November 10, 2026

AbbVie expands Oxford R&D facility with new £120m UK research commitment

November 9, 2026

MedPharm appoints Jason Mieding as chief operating officer

November 8, 2026

UKRI backs five hubs developing AI tools for earlier disease detection

November 8, 2026